Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Early diagnosis and treatment of systemic-onset juvenile idiopathic arthritis are crucial for improvement.

Accurate diagnosis and effective treatment are crucial to manage and prevent the spread of skin fungal infections in animals.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Understanding how acne develops in different diseases could lead to new treatments.

The combination therapy was effective and well-tolerated, especially in young patients.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Combining microdermabrasion with steroid injections improves hair regrowth in scalp alopecia areata.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Researchers found certain genes are overactive and others are underactive in men with early balding, which could help create new treatments.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Different hair care practices and conditions affect African American hair and scalp health, requiring specialized knowledge for treatment.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Curcumin applied to the skin can start hair growth in mice.

The back of the scalp has more nerve fibers than the front, which may explain why some people feel more sensitivity there.

BMP signaling controls hair growth and skin color.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

Using isotretinoin gel and minoxidil solution together effectively regrows hair in most people with patchy hair loss.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Early detection of Graham-Little-Piccardi-Lasseur syndrome is key for better management.

Early recognition and tailored treatment are crucial for managing overlapping systemic lupus erythematosus and systemic sclerosis.

A patient's gum problems worsened after using cyclosporine for a scalp condition, but improved with a lower dose.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Early detection of chemotherapy side effects allows treatment adjustments, improving patient outcomes.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.